| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $1.85B | +2.0% |
| Cost of Revenue | $477.7M | -0.6% |
| Gross Profit | $1.37B | +3.0% |
| R&D Expense | $929.5M | +0.5% |
| SG&A Expense | $268.5M | -34.5% |
| Operating Income | -$479.1M | +36.6% |
| Pre-tax Income | -$395.2M | +40.8% |
| Income Tax | $6.3M | +321.2% |
| Net Income | -$402.8M |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $2.06B | +35.5% |
| Accounts Receivable | $643.6M | +12.2% |
| Current Assets | $2.81B | +26.4% |
| Total Assets | $6.84B | +1.5% |
| Current Liabilities | $1.53B | +71.5% |
| Total Liabilities | $3.34B | +0.9% |
| Stockholders' Equity | $3.24B | +1.5% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $423.0M | +34.0% |
| Capital Expenditures | $19.0M | -35.6% |
| Investing Cash Flow | -$24.0M | +43.4% |
| Financing Cash Flow | $110.1M | +132.5% |
| Free Cash Flow | $403.9M | +41.2% |
| +39.4% |
| EPS (Basic) | -$0.96 | +42.9% |
| EPS (Diluted) | -$0.96 | +42.9% |